84 related articles for article (PubMed ID: 8552572)
21. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetics and molecular biology of soft tissue tumors.
Fletcher JA
Monogr Pathol; 1996; 38():37-64. PubMed ID: 8744274
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
26. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
[TBL] [Abstract][Full Text] [Related]
30. [Immunologic presentation of P53 protein in cell nucleus of soft tissue sarcoma].
Budach V
Strahlenther Onkol; 1995 Jan; 171(1):55-6. PubMed ID: 7839308
[No Abstract] [Full Text] [Related]
31. Recombinant human retinoblastoma protein inhibits cancer cell growth.
Pagliaro LC; Antelman D; Johnson DE; Machemer T; McCulloch EA; Freireich EJ; Stass SA; Shepard HM; Maneval D; Gutterman JU
Cell Growth Differ; 1995 Jun; 6(6):673-80. PubMed ID: 7669721
[TBL] [Abstract][Full Text] [Related]
32. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
[TBL] [Abstract][Full Text] [Related]
33. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
Porter PL; Gown AM; Kramp SG; Coltrera MD
Am J Pathol; 1992 Jan; 140(1):145-53. PubMed ID: 1731521
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional control of the proliferation cluster by the tumor suppressor p53.
Brosh R; Rotter V
Mol Biosyst; 2010 Jan; 6(1):17-29. PubMed ID: 20024063
[TBL] [Abstract][Full Text] [Related]
35. Tumor volume growth and cell proliferation in an estradiol resistant human endometrial adenocarcinoma growing in nude mice.
Horvath G; Andersson H; Mellqvist L; Leser G; Delle U
In Vivo; 1994; 8(2):259-62. PubMed ID: 7919131
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of p53 tumor suppressor protein in porokeratosis.
Magee JW; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):187-90. PubMed ID: 8304757
[TBL] [Abstract][Full Text] [Related]
37. p53 mutant gene expression in paraffin embedded and fresh frozen tissue of different urogenital tumors.
Kuczyk MA; Allhoff EP; Serth J; Hervatin C; Jonas U
Investig Urol (Berl); 1994; 5():12-5. PubMed ID: 7719291
[No Abstract] [Full Text] [Related]
38. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.
Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493
[TBL] [Abstract][Full Text] [Related]
39. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
van den Berg FM; Baas IO; Polak MM; Offerhaus GJ
Am J Pathol; 1993 Feb; 142(2):381-5. PubMed ID: 8434637
[TBL] [Abstract][Full Text] [Related]
40. P53 overexpression in human soft tissue sarcomas: relation to biological aggressiveness.
Toffoli G; Doglioni C; Cernigoi C; Frustaci S; Perin T; Canal B; Boiocchi M
Ann Oncol; 1994 Feb; 5(2):167-72. PubMed ID: 8186161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
